Quarterly report pursuant to Section 13 or 15(d)

Transactions Affecting Stockholders' Equity - Schedule of Stock Options Granted (Details)

v3.19.2
Transactions Affecting Stockholders' Equity - Schedule of Stock Options Granted (Details) - USD ($)
$ / shares in Units, $ in Thousands
 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Equity [Abstract]    
Number of Shares Options Outstanding - Beginning 2,980 980
Number of Shares, Granted   2,330
Number of Shares, Cashless exercised   (250)
Number of Shares, Cash exercised   (240)
Number of Shares, Forfeited (80)  
Number of Shares Options Outstanding - End 2,900 2,820
Number of Shares Options Vested and Exercisable 1,199 539
Weighted Average Exercise Price Options Outstanding - Beginning $ 1.82 $ 1.82
Weighted Average Exercise Price, Granted   2.00
Weighted Average Exercise Price, Cashless exercised   1.86
Weighted Average Exercise Price, Cash exercised   1.41
Weighted Average Exercise Price, Forfeited 2.87  
Weighted Average Exercise Price Options Outstanding - End 1.85 2.00
Weighted Average Exercise Price, Options Vested and Exercisable $ 1.88 $ 1.88
Weighted Average Remaining Contractual Life (in Years) - Beginning 4 years 9 months 18 days 4 years 9 months 18 days
Weighted Average Remaining Contractual Life (in Years) - Ending 3 years 10 months 25 days 4 years 10 months 25 days
Weighted Average Remaining Contractual Life (in Years) - Options Vested and Exercisable 3 years 9 months 18 days 2 years 4 months 24 days
Total Intrinsic Value - Beginning $ 3,235 $ 31
Total Intrinsic Value - Ending 4,450 422
Total Intrinsic Value, Options Vested and Exercisable $ 1,915 $ 150